4 key notes on Stryker mid-year

Written by Mackenzie Garrity | July 20, 2017 | Print  |

According to Market Realist, Stryker saw an 18.5 percent year over year growth in the first quarter of 2017. The company is now looking to expand its interventional spine segment.

Here are four takeaways:


1. While the company experienced growth, the neurotechnology and spine segment contributed the least to Stryker's revenue.


2. Recently, Stryker received FDA clearance for its MultiGen 2 RF generator to help physicians perform radiofrequency ablations.


3. Stryker is confident in their expected sales for the remaining year and plans to launch interventional spine, 3D printing and titanium platforms.


4. Competing companies include Medtronic, NuVasive and Johnson & Johnson.


More articles on devices:
Understanding the Science Behind the Hype
Simplify Medical reports $21M financing round; funds to support Simplify Disc clinical trials: 6 notes
North American spinal implants market to hit $7B by 2024 – 3 observations

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers